Pharmaceutical News

RSS

Blood pressure-lowering medication appears to kick start brain recovery after stroke

A commonly prescribed blood pressure-lowering medication appears to kick start recovery in the unaffected brain hemisphere after a stroke by boosting blood vessel growth, a new University of Georgia study has found.

22 Oct 2011

Participants invited for DHA-rich fish oil supplement study on mental performance

A particular fish oil (omega-3) supplement has been shown to improve blood flow to the brain during mental activity and to impact on certain aspects of mental performance in young adults, according to research from Northumbria University.

21 Oct 2011

Watson receives FDA approval for Androderm lower-dose formulations

Watson Pharmaceuticals, Inc. today announced that the U.S. Food and Drug Administration approved its Androderm (testosterone transdermal system) 2 mg and 4 mg formulation.

21 Oct 2011

RSV medication from specialty pharmacies increases likelihood of children receiving recommended doses

Children given an injectable medication to help prevent severe respiratory illness had a 17.6 percent higher likelihood of receiving the American Academy of Pediatrics (AAP) recommended doses when they were administered through a specialty pharmacy rather than a traditional pharmacy, according to a new study released today by pharmacy benefit manager Prime Therapeutics (Prime).

21 Oct 2011

Pradaxa for stroke treatment results in higher costs

Treating patients with the new blood thinning medication dabigatran (Pradaxa), instead of warfarin results in significantly higher per patient costs and higher net costs per stroke avoided, according to a new study by pharmacy benefit manager Prime Therapeutics (Prime).The study will be presented today at the Academy of Managed Care Pharmacy's Educational Conference in Atlanta, Ga.

21 Oct 2011

NPR: The Abbott Lab breakup

Abbott Labs is splitting up. The diversified maker of medical products will become two companies: one focused on brand-name prescription drugs and the second on the other stuff, including medical devices, diagnostic tests and baby formula.

21 Oct 2011

Preclinical data from Teva's COPAXONE study on multiple sclerosis

Teva Pharmaceutical Industries Ltd. today announced preclinical data demonstrating reparative and neuroprotective effects of treatment with COPAXONE (glatiramer acetate injection) in experimental autoimmune encephalomyelitis (EAE) models.

21 Oct 2011

The Guardian interviews GlaxoSmithKline lead researcher about new malaria vaccine

The Guardian features an interview with Moncef Slaoui, now chair of research and development at GlaxoSmithKline, who discusses his 23-year involvement in the research leading to the RTS,S malaria vaccine that has shown to halve the risk of malaria among African children.

21 Oct 2011

Aid groups, health ministry plan to administer oral cholera vaccine to 100,000 Haitians

Working in conjunction with the Haitian Ministry of Health and the Haitian aid group GHESKIO, Boston-based Partners In Health (PIH) will begin an immunization campaign in January aimed at providing two doses of the oral cholera vaccine Shanchol "to 100,000 Haitians living in two vulnerable communities: a neighborhood in Port-au-Prince, where potable water and latrines are luxuries, and to an isolated rural village in the lower Artibonite Valley region," the Miami Herald reports.

21 Oct 2011

No unique link between first-trimester ACE inhibitor use and birth defects

Women who take angiotensin-converting enzyme (ACE) inhibitors to treat high blood pressure in the first trimester of their pregnancies are at no greater risk of having babies with birth defects than are women who take other types of high blood pressure medication or who take no blood pressure drugs, according to a new study from the U.S. Department of Health and Human Services' (HHS) Agency for Healthcare Research and Quality.

21 Oct 2011

Treating TB, HIV co-infections early, aggressively can save lives, multiple studies show

"Treating tuberculosis (TB) and HIV infections at the same time can be a challenge for patients and their doctors, but attacking both diseases early and aggressively isn't harmful and could save the lives of those who are sickest," according to a global study led by researchers from the University of California, San Francisco (UCSF) and published Wednesday in the New England Journal of Medicine (NEJM), the San Francisco Chronicle reports.

21 Oct 2011

Gastroenterologist cautions against over-prescription of acid-suppressing drugs in infants

Frequent spitting up, irritability, and unexplained crying in infants can be very distressing to parents. Pediatricians often prescribe acid-suppressing drugs for these symptoms in an effort to treat infants for gastroesophageal reflux disease (GERD); however, GERD is an uncommon cause of these symptoms in otherwise thriving infants.

21 Oct 2011

Soy protein can help lower blood lipids in healthy individuals

A new study published online in the European Journal of Clinical Nutrition shows that soy protein compared to dairy milk protein supplementation improves the lipid profile in healthy individuals.

21 Oct 2011

CERT gene silencing makes breast cancer cells more sensitive to drugs

CANCER RESEARCH UK scientists have discovered that switching off a gene called CERT makes breast cancer cells more sensitive to a range of drugs. The research is published in the Journal of Pathology.

21 Oct 2011

Byetta combination with insulin glargine gets FDA nod in type 2 diabetes

The US Food and Drugs Administration (FDA) has approved Byetta (exenatide) injection as add-on treatment for use with insulin glargine, together with exercise and diet for diabetes type 2 patients who are not responding well enough to glargine alone. Byetta's add-on therapy is for those on glargine with metformin and/or a TZD (thiazolidinedione) or without.

20 Oct 2011

Study: Women still have hot flushes/night sweats years after menopause

Women still have hot flushes and night sweats years after the menopause finds a new study published today in BJOG: An International Journal of Obstetrics and Gynaecology.

20 Oct 2011

Study examines potential benefits of discordant couple HIV therapy

A new study published online in the journal AIDS uses mathematical models to predict the potential impact of treating discordant couples with antiretroviral therapy, according to a Columbia University Mailman School of Public Health press release.

20 Oct 2011

Three factors appear to correlate with mortality for a patient after surgery

Duke University Medical Center researchers have verified data that suggest three medical factors appear to correlate with mortality for a patient who has been under anesthesia for an operation.

20 Oct 2011

Tenofovir gel shows promise against HSV infection

HIV infection is commonly associated with other sexual infections, such as herpes simplex virus (HSV). Infection with HSV facilitates the risk of HIV infection and negatively impacts the clinical course of HIV disease. Therefore, it would be highly beneficial to identify multi-faceted microbicide compounds that are efficient against HIV-1 and other sexually transmitted infections.

20 Oct 2011

Ipsen, Syntaxin collaborate to develop new botulinum toxins

Ipsen and Syntaxin, a biotechnology company specialising in innovative biopharmaceutical therapies targeting cell secretion pathways, announced today a global strategic collaboration to explore the discovery and development of new compounds in the field of botulinum toxins.

20 Oct 2011

Pharmaceutical News

Blood pressure-lowering medication appears to kick start brain recovery after stroke

Participants invited for DHA-rich fish oil supplement study on mental performance

Watson receives FDA approval for Androderm lower-dose formulations

RSV medication from specialty pharmacies increases likelihood of children receiving recommended doses

Pradaxa for stroke treatment results in higher costs

NPR: The Abbott Lab breakup

Preclinical data from Teva's COPAXONE study on multiple sclerosis

The Guardian interviews GlaxoSmithKline lead researcher about new malaria vaccine

Aid groups, health ministry plan to administer oral cholera vaccine to 100,000 Haitians

No unique link between first-trimester ACE inhibitor use and birth defects

Treating TB, HIV co-infections early, aggressively can save lives, multiple studies show

Gastroenterologist cautions against over-prescription of acid-suppressing drugs in infants

Soy protein can help lower blood lipids in healthy individuals

CERT gene silencing makes breast cancer cells more sensitive to drugs

Byetta combination with insulin glargine gets FDA nod in type 2 diabetes

Study: Women still have hot flushes/night sweats years after menopause

Study examines potential benefits of discordant couple HIV therapy

Three factors appear to correlate with mortality for a patient after surgery

Tenofovir gel shows promise against HSV infection

Ipsen, Syntaxin collaborate to develop new botulinum toxins

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Latest News